1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Indonesia Healthcare Outlook : Value Propositions and Market Entry Guides for Investors

Methodology and Scope

This research service focuses on the Indonesian healthcare market, providing a detailed overview of the investment scenario in particular. A brief overview of the tendering process, incentives for investors, and distributor network have also been included.
This study broadly discusses the revenue or financial forecasting of the healthcare market, but does not provide a discussion of the companies which are involved with research & development (R&D) or services in details.
Company profiles of those companies which are currently or imminently prominent and or may be of interest for investors in Indonesia have been included.
The information contained in this research service was derived from published sources including the following: Government of Indonesia Websites, healthcare company websites, World Health Organization (WHO) data, World Bank data, International Monetary Fund (IMF) and press releases, public sources, Frost & Sullivan’s internal data bank, and industry key opinion leaders (KOLs). Primary and secondary research methodologies were used to gather and analyse the data presented in this study.

What Does the Indonesian Healthcare Market Offer?

To Cover All Citizens by 2019
• Demand for More Hospital Beds
• Demand for More Drugs (Generics)
• Demand for More Medical Equipment
• Demand for More Diagnostic Tests
• Demand for Qualified and Skilled Healthcare Professionals

With an increase in income per capita, and the expected subsidisation of medication and hospital insurance by the government, people are likely to move away from self-medication to seek treatment in clinics and hospitals. In anticipation, a few non-hospital participants such as PT Kalbe Farma Tbk have already started planning their entry into the new private hospitals and clinics market in 2013. They also have plans for catering to affluent Indonesians who can afford out-of-pocket (OOP) payments and seek quality treatment over subsidized treatment. The World Bank estimates Indonesia’s National Health Insurance, Jaminan Kesehatan Nasional (JKN), to cost $x-$x billion per year once it is fully implemented. Will that imply subsidised healthcare insurance to another x million citizens? Will that also create the demand for healthcare services in Indonesia?

What are the Teething Issues Post Implementation of National Health Insurance (JKN)?

Selected participating hospitals in the JKN have raised concerns over increasing working capital requirements after JKN implementation due to delays in receiving reimbursement from the government. One public hospital in Kalimantan, Timur, has indicated that it had received only x% of the payment for its January claims (reported on 22, February 2014). This is indicative of the teething issues which were anticipated post the implementation of JKN from January 2014. However, the hospital market is hopeful that these issues will be soon taken care of and things will improve by 2015.

How can the Private Investor Benefit from the JKN Scheme?

There has been an increase in middle-class income and healthcare spending year-on-year (YOY). Moreover, a large number of patients are likely to opt for private hospitals and clinics as well as diagnostic centres to avoid long queues in public hospitals. Due to this, the demand for medicines, equipment, and private hospitals will increase and further drive the Indonesian healthcare market 2015 onwards.

Table Of Contents

Indonesia Healthcare Outlook : Value Propositions and Market Entry Guides for Investors
Executive Summary 9
• What Does the Indonesian Healthcare Market Offer? 10
• Who Will Benefit the Most from National Health Insurance? 11
• What are the Teething Issues Post Implementation of National Health Insurance
(JKN)? 12
• Has the Patient Volume Increased as Anticipated? 13
• How can the Private Investor Benefit from the JKN Scheme? 14
• Which Companies are Ahead of Others? 17
• What are the Current Roadblocks? 18
• Market Segmentation—Healthcare Markets in Indonesia 19
• Key Questions this Study Will Answer 20
• CEO's Perspective 21
• Mergers, Acquisitions, and Partnerships—Some Key Deals 22
• Key Companies to Watch Out-Hospital Market 23
• Key Companies to Watch Out-Medical Technology (MT) Market 24
• Key Companies to Watch Out-Pharmaceutical Market 25
Healthcare Market in Indonesia 26
• Indonesia—Demographical Overview 27
• Indonesia—Healthcare Expenditure 28
• PESTLE Analysis 29
• What are the Market Attractions in Indonesia? 30
• Market Engineering Measurements 31
• Market Engineering Measurements—Segments to Watch Out 32
• SWOT Analysis of the Indonesian Healthcare Market 33
Drivers and Restraints 34
• Market Drivers 35
• Drivers Explained 36
• Market Restraints 38
• Restraints Explained 39
Private Hospital Market in Indonesia 41
• Indonesian Hospital Market—Overview 42
• Indonesian Healthcare Delivery System by Infrastructure 43
• Indonesian Hospital Classification by Class 44
• Indonesian Hospital Market—Number of Hospitals (Public and Private) 45
• Indonesian Hospital Market—Highlights 46
• Regulations for Non-Indonesian Stakeholders Planning Entry into the Private
Hospital Market and Implications 47
• Ease of Entry for Stakeholders in the Private Hospital Market 48
• Revenue Forecast—Private Hospital Market 49
• Revenue Forecast Discussion 50
• Private Hospital Market Competitors in Indonesia 51
• New Market Opportunity—Private Hospital Market 53
In-Vitro Diagnostics (IVD) Market in Indonesia 54
• Indonesian IVD Market—Overview 55
• Regulations for Non-Indonesian Stakeholders Planning to Enter the IVD Market and
Implications 57
• Ease of Entry for Stakeholders in the IVD Market 58
• Revenue Forecast—IVD Market Indonesia 59
• Revenue Forecast Discussion 60
• IVD Market Competitors in Indonesia 61
• New Market Opportunity—IVD Market 62
Medical Technologies (MT) Market in Indonesia 63
• Indonesian MT Market—Overview 64
• Indonesian MT Market—Segmentation 66
• Indonesian MT Market—Highlights 67
• Regulations for Non-Indonesian Stakeholders Planning to Enter the MT Market and
Implications 68
• E-Catalogue—Medical Devices 69
• Ease of Entry for Stakeholders in the MT Market 71
• Revenue Forecast—MT Market Indonesia 72
• Revenue Forecast—Consumables Market Indonesia 73
• Revenue Forecast—Medical Imaging Market Indonesia 74
• Revenue Forecast—Radiation Devices Market Indonesia 75
• Revenue Forecast Discussion 76
• Medical Imaging Market Competitors in Indonesia 77
• Medical Devices Market Competitors in Indonesia 78
• Market Opportunity—MT Market Indonesia 79
Pharmaceutical Market in Indonesia 80
• Indonesian Pharmaceutical Market—Overview 81
• Indonesian Pharmaceutical Market—Domestic Companies 82
• Indonesian Pharmaceutical Market—Communication Channel Overview 83
• Indonesian Pharmaceutical Market—Distribution Channel Overview 84
• Indonesian Pharmaceutical Market—Highlights 85
• Regulations for Non-Indonesian Stakeholders Planning to Enter the
Pharmaceutical Market and Implications 86
• Ease of Entry for Stakeholders in the Pharmaceutical Market 88
• Revenue Forecast—Pharmaceutical Market Indonesia 89
• Revenue Forecast Discussion 90
• Competitors in the Pharmaceutical Market Indonesia 91
• Market Opportunity—Pharmaceutical Market Indonesia 92
Strategic Recommendations 93
• Opportunities for Foreign Investors 94
• Future of the Indonesian Healthcare Market 95
• 3 Key Predictions 96
• The Last Word 97
• Frost and Sullivan Awards for Indonesian Healthcare Market in 2014 98
Appendix 100
• Abbreviations 101
• Market Engineering Methodology 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.